Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia
N Gardiner, M Lawler, J O'Riordan, M DeArce… - Bone marrow …, 1997 - nature.com
Chronic myeloid leukaemia (CML) can be treated successfully with allogeneic bone marrow
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
N GARDINER, M LAWLER… - Leukemia …, 1997 - search.ebscohost.com
Abstract Although Chronic Myeloid Leukaemia (CML) can be treated successfully with
allogeneic bone marrow transplantation (BMT), leukaemia relapse remains a significant …
allogeneic bone marrow transplantation (BMT), leukaemia relapse remains a significant …
Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
S Mackinnon, L Barnett, G Heller, RJ O'Reilly - 1994 - ashpublications.org
Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …
Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid …
J Roman, C Martin, A Torres, A Garcia… - Leukemia & …, 1998 - Taylor & Francis
Determination of hematological chimerism could be helpful in understanding the biology of
leukemic relapse after allogeneic bone marrow transplant (BMT) for chronic myeloid …
leukemic relapse after allogeneic bone marrow transplant (BMT) for chronic myeloid …
Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous …
J Román, J Serrano, A Jiménez, JA Castillejo… - …, 2000 - haematologica.org
BACKGROUND AND OBJECTIVE: Although bcr-abl polymerase chain reaction (PCR)
positivity after bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …
positivity after bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …
Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow …
MC Rapanotti, W Arcese, S Buffolino, AP Iori… - Bone marrow …, 1997 - nature.com
Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …
[HTML][HTML] Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different …
E Roux, K Abeti, D Speiser, C Helg, B Chapuis… - Blood, 1993 - Elsevier
We have characterized mixed chimerism (MC) in five patients with chronic myeloid leukemia
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …
Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies
LD Petz, P Yam, RB Wallace, AD Stock, G de Lange… - 1987 - ashpublications.org
Abstract Twenty-nine of 172 patients (17%) who received an allogeneic bone marrow
transplant (BMT) from histocompatible sibling donors for hematologic malignancies were …
transplant (BMT) from histocompatible sibling donors for hematologic malignancies were …
[引用][C] Mixed chimerism after bone marrow transplantation and the risk of relapse
E Roux, C Helg, B Chapius, M Jeannet, E Roosnek - 1994 - ashpublications.org
After bone marrow transplantation, recipient hematopoietic cells are usually eradicated by
the combination of the cytotoxic preconditioning regimen and the allogeneic effect of the …
the combination of the cytotoxic preconditioning regimen and the allogeneic effect of the …
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone …
AH Elmaagacli, HW Becks, DW Beelen… - Bone marrow …, 1995 - europepmc.org
We investigated the persistence of host-type hematopoiesis as defined by mixed chimerism
(MC) in 28 male patients with chronic myelogenous leukemia (CML) who underwent …
(MC) in 28 male patients with chronic myelogenous leukemia (CML) who underwent …